BRPI0810179A2 - Composições de oligo-guluronato e galacturonato - Google Patents

Composições de oligo-guluronato e galacturonato

Info

Publication number: BRPI0810179A2
Authority: BR; Brazil
Prior art keywords: guluronate; galacturonate; oligo; compositions
Prior art date: 2007-04-12

Application number

BRPI0810179-5A2A

Other languages

English (en)

Inventor

Catherine Taylor

Kurt Ingar Draget

Olav Asmund Smidsrod

Original Assignee

Ntnu Technology Transfer As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-12

Filing date

2008-04-11

Publication date

2014-12-30

2008-04-11 Application filed by Ntnu Technology Transfer As filed Critical Ntnu Technology Transfer As

2014-12-30 Publication of BRPI0810179A2 publication Critical patent/BRPI0810179A2/pt

2019-12-10 Publication of BRPI0810179B1 publication Critical patent/BRPI0810179B1/pt

2021-05-25 Publication of BRPI0810179B8 publication Critical patent/BRPI0810179B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Otolaryngology (AREA)
Pregnancy & Childbirth (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0810179A 2007-04-12 2008-04-11 composições de oligoguluronato e galacturonato e usos dos mesmos BRPI0810179B8 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0707096.4A GB0707096D0 (en)	2007-04-12	2007-04-12	Method
PCT/GB2008/001287 WO2008125828A2 (en)	2007-04-12	2008-04-11	Oligo-guluronate and galacturonate compositions

Publications (3)

Publication Number	Publication Date
BRPI0810179A2 true BRPI0810179A2 (pt)	2014-12-30
BRPI0810179B1 BRPI0810179B1 (pt)	2019-12-10
BRPI0810179B8 BRPI0810179B8 (pt)	2021-05-25

Family

ID=38116633

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0810179A BRPI0810179B8 (pt)	2007-04-12	2008-04-11	composições de oligoguluronato e galacturonato e usos dos mesmos

Country Status (14)

Country	Link
US (1)	US8841279B2 (pt)
EP (2)	EP2500025B1 (pt)
JP (2)	JP5649443B2 (pt)
KR (2)	KR101472245B1 (pt)
CN (1)	CN101711159B (pt)
AU (1)	AU2008237710B2 (pt)
BR (1)	BRPI0810179B8 (pt)
CA (2)	CA2683914C (pt)
DK (2)	DK2155211T3 (pt)
EA (1)	EA018776B1 (pt)
ES (2)	ES2553962T3 (pt)
GB (1)	GB0707096D0 (pt)
MX (2)	MX352972B (pt)
WO (1)	WO2008125828A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2430881B (en)	2005-10-06	2010-10-13	Ntnu Technology Transfer As	Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en)	2007-04-12	2007-05-23	Ntnu Technology Transfer As	Method
SI2268142T1 (sl) *	2007-11-27	2017-09-29	Algipharma As	Uporaba alginiranih oligomerov v boju proti biofilmom
GB0904942D0 (en) *	2009-03-23	2009-05-06	Ntnu Technology Transfer As	Composition
GB0904941D0 (en) *	2009-03-23	2009-05-06	Ntnu Technology Transfer As	Composition
RU2586253C2 (ru)	2009-06-03	2016-06-10	АльгиФарма АС	Обработка акинетобактерий альгинатными олигомерами и антибиотиками
GB0909529D0 (en)	2009-06-03	2009-07-15	Algipharma Ipr As	Alginate oligomers for the inhibition of microbial adherence to surfaces
GB0909557D0 (en)	2009-06-03	2009-07-15	Algipharma Ipr As	Anti-microbial alginate oligomers
JO3676B1 (ar) *	2009-07-27	2020-08-27	Arc Medical Devices Inc	مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
GB201116010D0 (en)	2011-09-15	2011-10-26	Algipharma As	Use of alginate oligomers to enhance the effects of antifungal agents
GB201322777D0 (en)	2013-12-20	2014-02-05	Algipharma As	Use of alginate oligomers as blood anticoagulants
JP2017501221A (ja) *	2013-12-23	2017-01-12	ノルウェージャンユニバーシティオブサイエンスアンドテクノロジー（エヌティーエヌユー）	がん治療におけるオリゴウロン酸塩の使用
CN106029079A (zh) *	2014-02-28	2016-10-12	阿尔吉法玛公司	藻酸盐低聚物在治疗囊性纤维化和与缺陷性cftr离子通道功能相关的其它疾病中的应用
FR3024358B1 (fr) *	2014-08-01	2017-11-10	Soc De Courtage Et De Diffusion Codif Int	Compositions cosmetiques et complements alimentaires neuro-protecteurs comprenant de l'oligoalginate ayant un degre de polymerisation de 10 pour lutter contre le vieillissement de la peau.
GB201415381D0 (en)	2014-08-29	2014-10-15	Algipharma As	Inhalable powder formulations of alginate oligomers
GB201504878D0 (en) *	2015-03-23	2015-05-06	Algipharma As	Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
GB201517639D0 (en)	2015-10-06	2015-11-18	Algipharma As	Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
AU2018205823A1 (en)	2017-01-03	2019-07-18	The University Of North Carolina At Chapel Hill	Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
US11723914B2 (en)	2017-03-28	2023-08-15	The University Of North Carolina At Chapel Hill	Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto
WO2019099525A1 (en)	2017-11-15	2019-05-23	The University Of North Carolina At Chapel Hill	Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto
JP7565588B2 (ja)	2018-03-06	2024-10-11	ザユニバーシティオブノースカロライナアットチャペルヒル	生分解性の抗菌性足場としての一酸化窒素放出性シクロデキストリンおよびそれに関する方法
GB201812473D0 (en)	2018-07-31	2018-09-12	Algipharma As	Method for the qualitative and quantitative detection of alginate oligomers in body fluids
CA3124673A1 (en)	2018-12-28	2020-07-02	The University Of North Carolina At Chapel Hill	Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto
US11684597B2 (en)	2019-01-28	2023-06-27	The United States Of America As Represented By The Secretary Of The Army	Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility
GB201908639D0 (en)	2019-06-17	2019-07-31	Algipharma Ipr As	Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense microstructure
CN121001710A (zh)	2022-12-30	2025-11-21	阿尔吉法玛公司	提高口服多肽治疗剂的全身生物利用度的组合物和方法
WO2026008878A1 (en)	2024-07-04	2026-01-08	Algipharma As	Antimycotic polyene-alginate oligomer conjugates

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL297511A (pt)	1956-12-20
FR7576M (pt)	1968-03-27	1970-01-05
HU172831B (hu) *	1976-03-31	1978-12-28	Egyt Gyogyszervegyeszeti Gyar	Sposob poluchenija kompleksov oligo- i poligalakturonnyk kislot s ionami zhiznenno vazhnykh metallov
JPS6176413A (ja)	1984-09-21	1986-04-18	Junzo Sunamoto	吸水性高分子によりカプセル化されたリポソ−ムの製造法
DD268865A1 (de)	1987-01-16	1989-06-14	Adw Ddr	Verfahren zur herstellung eines pharmazeutischen praeparates
US4898852A (en)	1987-06-02	1990-02-06	Walsh William E	Cyclopolgalcturonic acid composition and treatment
US4855128A (en)	1988-01-14	1989-08-08	Warner-Lambert Company	Saccharide inhibition of dental plaque
JP2641472B2 (ja)	1988-01-30	1997-08-13	日本レダリー株式会社	感染症治療剤
JPH05502863A (ja)	1989-12-05	1993-05-20	トランセル・コーポレイション	生体内適用および埋め込み用コーティング組成物同種グルロン酸―アルギン酸塩およびその使用方法
US5459054A (en) *	1989-12-05	1995-10-17	Neocrin Company	Cells encapsulated in alginate containing a high content of a- l- guluronic acid
WO1991011205A1 (en)	1990-01-23	1991-08-08	Trancel Corporation	Mannuronic acid containing alginate wound healing composition and method
US5166137A (en)	1991-03-27	1992-11-24	Nobipols Forskningsstiftelse	Guluronic acid polymers and use of same for inhibition of cytokine production
US5460957A (en) *	1992-04-28	1995-10-24	Maruha Corporation	Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate
HU213872B (en)	1993-09-08	1997-11-28	Mta Koezponti Kemiai Kutato In	Oligo- and polygalacturonate mixed complex, pharmaceutical and food compositions containing them, further process for preparing these compounds
DE4330773A1 (de) *	1993-09-10	1995-03-16	Laevosan Gmbh & Co Kg	Blockierung der Anlagerung von Keimen an menschliche Zellen
JP2828391B2 (ja) *	1993-10-29	1998-11-25	東燃株式会社	オリゴ糖を表面に有するリポソーム
AUPM322393A0 (en)	1993-12-24	1994-01-27	Austin Research Institute, The	Mucin carbohydrate compounds and their use in immunotherapy
US5795587A (en) *	1995-01-23	1998-08-18	University Of Pittsburgh	Stable lipid-comprising drug delivery complexes and methods for their production
CA2235069C (en) *	1995-10-19	2010-12-14	Advanced Reproduction Technologies, Inc.	Methods and compositions to improve germ cell and embryo survival and function
JP3512553B2 (ja)	1996-01-30	2004-03-29	ポーラ化成工業株式会社	便秘抑制剤及びそれを含有する組成物
FR2747045B1 (fr)	1996-04-05	1998-06-26	Hooreman Michel	Nouveau medicament optimisant la viscosite des mucus et ameliorant le fonctionnement de l'intestin
NO305441B1 (no)	1996-07-12	1999-05-31	Norsk Hydro As	Anvendelse av G-blokk polysakkarider
WO1998013024A2 (en)	1996-09-27	1998-04-02	Hyal Pharmaceutical Corporation	Hyaluronic drug delivery system
US20070185032A1 (en) *	1996-12-11	2007-08-09	Praecis Pharmaceuticals, Inc.	Pharmaceutical formulations for sustained drug delivery
NO305033B1 (no) *	1997-05-09	1999-03-22	Algipharma As	Fremgangsmate for fremstilling av uronsyreblokker fra alginat
US6339075B1 (en) *	1997-06-30	2002-01-15	The University Of British Columbia	Use of dextran and other polysaccharides to improve mucus clearance
KR100219918B1 (ko)	1997-07-03	1999-09-01	김윤	대장선택적 약물전달용 조성물
JP3849144B2 (ja) *	1997-12-31	2006-11-22	ソニー株式会社	符号化データ出力装置及び方法並びに符号化データ制御装置及び方法
JP3932679B2 (ja) *	1998-07-21	2007-06-20	セイコーエプソン株式会社	ポリグルロン酸の製造法
US6290987B1 (en)	1998-09-27	2001-09-18	Generex Pharmaceuticals, Inc.	Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US20040224922A1 (en) *	1999-08-26	2004-11-11	Malcolm King	Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto
HK1047246A1 (zh)	1999-08-26	2003-02-14	艾伯塔大学理事会	带电葡聚糖作为粘液活性剂的用途及有关方法和药物组合物
US6458387B1 (en)	1999-10-18	2002-10-01	Epic Therapeutics, Inc.	Sustained release microspheres
JP2001155905A (ja) *	1999-11-24	2001-06-08	Nec Corp	半導体装置およびトリミング方法ならびに記録媒体
US7785625B2 (en) *	2000-01-14	2010-08-31	Lg Life Sciences, Limited	Lipophilic-coated microparticle containing a protein drug and formulation comprising same
KR100501584B1 (ko) *	2000-02-03	2005-07-18	(주)케이비피	저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
DE10006989A1 (de) *	2000-02-16	2001-08-23	Nutricia Nv	Antiadhäsive Kohlenhydratmischung
DE60143566D1 (de)	2000-03-07	2011-01-13	Rush Presbyterian St Luke	Zusammensetzungen und deren Verwendung zum Abfangen und Inaktivieren pathogener Mikroben und Spermatozoen
WO2001072278A2 (en)	2000-03-30	2001-10-04	Generex Pharmaceuticals Inc.	Method for administering insulin to the buccal region
DE10019076A1 (de) *	2000-04-06	2001-10-18	Lang Christine	Verwendung von Polygalakturoniden als Lebensmittelzusatzstoffe
JP2002338493A (ja)	2000-10-23	2002-11-27	Genaera Corp	ムチン合成インヒビター
DE10057976B4 (de)	2000-11-22	2005-02-03	Südzucker AG Mannheim/Ochsenfurt	Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6440314B1 (en) *	2001-01-03	2002-08-27	Vulcan Chemical Technologies, Inc.	Method for destroying chlorite in solution
ITMI20010347A1 (it)	2001-02-21	2002-08-21	Grisotech S A	Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
US6610331B1 (en) *	2002-05-30	2003-08-26	Scott M. Sweazy	Fertility kit
JP2005145885A (ja) *	2003-11-14	2005-06-09	Japan Science & Technology Agency	アルギン酸オリゴマーからなる免疫機構賦活剤
ES2328048T3 (es)	2004-03-12	2009-11-06	Biodel, Inc.	Composiciones de insulina con absorcion mejorada.
US7745651B2 (en) *	2004-06-07	2010-06-29	Protiva Biotherapeutics, Inc.	Cationic lipids and methods of use
JP2006028041A (ja)	2004-07-13	2006-02-02	Ltt Bio-Pharma Co Ltd	核酸含有ナノ粒子
EP1714660A1 (en)	2005-04-21	2006-10-25	N.V. Nutricia	Uronic acid and probiotics
US7621036B2 (en)	2005-06-21	2009-11-24	Cardiomems, Inc.	Method of manufacturing implantable wireless sensor for in vivo pressure measurement
EP1745705A1 (en)	2005-07-20	2007-01-24	N.V. Nutricia	Process for preparing uronic acid oligosaccharides by extrusion
GB2430881B (en) *	2005-10-06	2010-10-13	Ntnu Technology Transfer As	Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
AU2006302744B8 (en)	2005-10-21	2011-02-10	Living Cell Products Pty Limited	Encapsulation system
GB0707096D0 (en)	2007-04-12	2007-05-23	Ntnu Technology Transfer As	Method
US20110130444A1 (en)	2007-05-04	2011-06-02	Stefan Moisyadi	Methods and compositions for targeted delivery of gene therapeutic vectors
JP2011520962A (ja)	2008-05-19	2011-07-21	ザユニバーシティオブノースカロライナアットチャペルヒル	新規カチオン性脂質を含む方法及び組成物

2007
- 2007-04-12 GB GBGB0707096.4A patent/GB0707096D0/en not_active Ceased
2008
- 2008-04-11 DK DK08736951.8T patent/DK2155211T3/en active
- 2008-04-11 ES ES08736951.8T patent/ES2553962T3/es active Active
- 2008-04-11 KR KR1020137022922A patent/KR101472245B1/ko active Active
- 2008-04-11 JP JP2010502572A patent/JP5649443B2/ja active Active
- 2008-04-11 CA CA2683914A patent/CA2683914C/en active Active
- 2008-04-11 WO PCT/GB2008/001287 patent/WO2008125828A2/en not_active Ceased
- 2008-04-11 AU AU2008237710A patent/AU2008237710B2/en active Active
- 2008-04-11 CN CN2008800196645A patent/CN101711159B/zh active Active
- 2008-04-11 CA CA2817754A patent/CA2817754C/en active Active
- 2008-04-11 MX MX2014005931A patent/MX352972B/es unknown
- 2008-04-11 US US12/595,818 patent/US8841279B2/en active Active
- 2008-04-11 ES ES12161928.2T patent/ES2655102T3/es active Active
- 2008-04-11 EP EP12161928.2A patent/EP2500025B1/en active Active
- 2008-04-11 EP EP08736951.8A patent/EP2155211B1/en active Active
- 2008-04-11 KR KR1020097023647A patent/KR101336459B1/ko active Active
- 2008-04-11 BR BRPI0810179A patent/BRPI0810179B8/pt not_active IP Right Cessation
- 2008-04-11 DK DK12161928.2T patent/DK2500025T3/en active
- 2008-04-11 EA EA200901299A patent/EA018776B1/ru unknown
- 2008-04-11 MX MX2009010889A patent/MX2009010889A/es active IP Right Grant
2014
- 2014-03-05 JP JP2014042608A patent/JP2014129401A/ja active Pending

Also Published As

Publication number	Publication date
CA2683914C (en)	2013-08-13
WO2008125828A3 (en)	2009-06-04
KR20130106446A (ko)	2013-09-27
EA200901299A1 (ru)	2010-06-30
BRPI0810179B8 (pt)	2021-05-25
JP5649443B2 (ja)	2015-01-07
EP2155211B1 (en)	2015-08-26
JP2010523636A (ja)	2010-07-15
EP2500025A1 (en)	2012-09-19
CN101711159A (zh)	2010-05-19
US8841279B2 (en)	2014-09-23
WO2008125828A2 (en)	2008-10-23
CA2683914A1 (en)	2008-10-23
EA018776B1 (ru)	2013-10-30
GB0707096D0 (en)	2007-05-23
MX2009010889A (es)	2009-10-28
US20100152122A1 (en)	2010-06-17
CA2817754C (en)	2014-12-09
AU2008237710B2 (en)	2014-02-06
JP2014129401A (ja)	2014-07-10
EP2155211A2 (en)	2010-02-24
ES2655102T3 (es)	2018-02-16
DK2500025T3 (en)	2018-01-15
DK2155211T3 (en)	2015-12-14
AU2008237710A1 (en)	2008-10-23
KR101336459B1 (ko)	2013-12-04
CA2817754A1 (en)	2008-10-23
MX352972B (es)	2017-12-15
EP2500025B1 (en)	2017-10-18
KR20100016492A (ko)	2010-02-12
BRPI0810179B1 (pt)	2019-12-10
CN101711159B (zh)	2012-06-27
KR101472245B1 (ko)	2014-12-11
ES2553962T3 (es)	2015-12-15

Publication	Publication Date	Title
BRPI0810179A2 (pt)	2014-12-30	Composições de oligo-guluronato e galacturonato
LTPA2019003I1 (lt)	2019-02-25	Nauji junginiai ir kompozicijos ir jų panaudojimo būdai
BRPI0906980A2 (pt)	2015-07-21	Composição de derivados e maleatados
EP2167043A4 (en)	2013-05-01	NEW USE CO-CRYSTAL COMPOSITIONS
PL3812360T3 (pl)	2024-04-08	Związki monochlorotrifluoropropenu oraz kompozycje i sposoby ich zastosowania
PT2424372T (pt)	2018-04-19	Composições antimicrobianas e métodos de uso relacionados
DOP2007000084A (es)	2007-12-31	Derivados de dihidropirazolopirimidinona
PL2214679T3 (pl)	2019-09-30	Kompozycje kortykosteroidów
BR112012005237A2 (pt)	2016-03-15	utilização de composições ternárias
BRPI1011587A2 (pt)	2016-03-22	compostos e composições terapèuticas
BRPI0913086A2 (pt)	2015-08-04	Composições antimicrobianas e métodos de uso
EP2136768A4 (en)	2013-04-17	Structured surfactant compositions
DK2011486T3 (da)	2012-09-03	Farmaceutiske sammensætninger af rifaximin
EP2124523A4 (en)	2010-08-04	BREEDING LINE P2428-5006090
PT2161038E (pt)	2014-03-10	Composições e suas utilizações dirigidas à huntingtina
LT2966175T (lt)	2019-08-26	Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
PL2150575T3 (pl)	2017-05-31	Kompozycja powłoki antyadhezyjnej i sposób jej wytwarzania
PT2356462T (pt)	2017-04-07	Composições e métodos anti-cxcr1
CR10562A (es)	2009-03-20	Nuevos derivados de piridazina
FI20096058A0 (fi)	2009-10-13	Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
DK2111555T3 (da)	2013-09-02	Diagnosticering af præeklampsi
BRPI0819449A2 (pt)	2014-10-14	Composições cosméticas de multietapas
CR10809A (es)	2009-06-25	Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
BRPI0813681A2 (pt)	2015-01-06	Detecção de coproantígeno de nematelminto
DK2358714T3 (da)	2012-08-20	Alkylcyclohexylethere af dihydrotetraazabenzoazulener

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-23	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-01-15	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-05-07	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-10-22	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-12-10	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/12/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/12/2019, OBSERVADAS AS CONDICOES LEGAIS
2020-05-05	B25G	Requested change of headquarter approved	Owner name: NTNU TECHNOLOGY TRANSFER AS (NO)
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/04/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2024-02-06	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 16A ANUIDADE.
2024-05-21	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2770 DE 06-02-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.